These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15168805)

  • 1. 6-Mercaptopurine is effective in Crohn's disease without concomitant steroids.
    Goldstein ES; Marion JF; Present DH
    Inflamm Bowel Dis; 2004 Mar; 10(2):79-84. PubMed ID: 15168805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease.
    Korelitz BI; Present DH
    Dig Dis Sci; 1985 Jan; 30(1):58-64. PubMed ID: 2856904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis.
    Warman JI; Korelitz BI; Fleisher MR; Janardhanam R
    J Clin Gastroenterol; 2003 Sep; 37(3):220-5. PubMed ID: 12960720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children.
    Jeshion WC; Larsen KL; Jawad AF; Piccoli DA; Verma R; Maller ES; Baldassano RN
    J Clin Gastroenterol; 2000 Apr; 30(3):294-8. PubMed ID: 10777191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G; Israel DM; Hassall E
    Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease.
    Colonna T; Korelitz BI
    Am J Gastroenterol; 1994 Mar; 89(3):362-6. PubMed ID: 8122645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.
    Cuffari C; Théorêt Y; Latour S; Seidman G
    Gut; 1996 Sep; 39(3):401-6. PubMed ID: 8949645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.
    Markowitz J; Grancher K; Kohn N; Lesser M; Daum F
    Gastroenterology; 2000 Oct; 119(4):895-902. PubMed ID: 11040176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease.
    Markowitz J; Rosa J; Grancher K; Aiges H; Daum F
    Gastroenterology; 1990 Nov; 99(5):1347-51. PubMed ID: 1976562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
    Hassard PV; Vasiliauskas EA; Kam LY; Targan SR; Abreu MT
    Inflamm Bowel Dis; 2000 Feb; 6(1):16-20. PubMed ID: 10701145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-mercaptopurine therapy in selected cases of corticosteroid-dependent Crohn's disease.
    Perrault J; Greseth JL; Tremaine WJ
    Mayo Clin Proc; 1991 May; 66(5):480-4. PubMed ID: 1674293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease.
    O'Brien JJ; Bayless TM; Bayless JA
    Gastroenterology; 1991 Jul; 101(1):39-46. PubMed ID: 2044925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
    Soh JS; Yun WJ; Kim KJ; Won CH; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
    Inflamm Bowel Dis; 2015 Apr; 21(4):832-9. PubMed ID: 25789922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease.
    Sultan K; Korelitz BI; Present D; Katz S; Sunday S; Shapira I
    Inflamm Bowel Dis; 2012 Oct; 18(10):1855-8. PubMed ID: 22241664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease].
    Hinojosa J; Molés JR; Nos P; Hoyos M; Ramírez JJ; Primo J; Fernández J; Berenguer J
    Rev Esp Enferm Dig; 1995 Nov; 87(11):775-80. PubMed ID: 8534531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease.
    Korelitz BI; Adler DJ; Mendelsohn RA; Sacknoff AL
    Am J Gastroenterol; 1993 Aug; 88(8):1198-205. PubMed ID: 8338087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity.
    Shafran I; Burgunder P
    Dig Dis Sci; 2010 Apr; 55(4):1079-84. PubMed ID: 20112064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-TNF therapy in treatment of luminal Crohn's disease].
    Marko B; Prka L
    Acta Med Croatica; 2013 Apr; 67(2):179-89. PubMed ID: 24471301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.